Related Experiment Video
Updated: May 15, 2026

08:22
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey
Lars Timmermann1, Michael Schüpbach, Frank Hertel
1Department of Neurology, University Hospital Cologne, Cologne, Germany. lars.timmermann@uk-koeln.de
European Neurology
|January 19, 2013
Summary
Rechargeable deep brain stimulation (DBS) devices offer high patient satisfaction, particularly for dystonia. Younger Parkinson's disease patients with technical skills may also benefit most from this advanced neurostimulation.
Area of Science:
- Neurology
- Biomedical Engineering
Background:
- Deep brain stimulation (DBS) is a key treatment for Parkinson's disease (PD), dystonia, and essential tremor (ET).
- Traditional DBS devices were nonrechargeable, requiring battery replacements every 3-5 years, causing patient inconvenience and surgical burden.
- The introduction of a smaller, lighter, rechargeable DBS device aims to improve patient experience and longevity (9 years).
Purpose of the Study:
- To evaluate patient satisfaction with the newly introduced rechargeable DBS system.
- To compare satisfaction levels across different neurological conditions (PD, dystonia, ET).
- To identify factors influencing patient satisfaction with rechargeable DBS technology.
Main Methods:
- A survey was administered to 21 patients (8 PD, 10 dystonia, 2 ET) 3 months post-implantation of a rechargeable DBS device.
- Patient satisfaction was systematically assessed regarding device comfort, function, and the recharging process.
Main Results:
- Overall patient satisfaction with the rechargeable DBS system was high at 83.3%.
- Dystonia patients reported lower satisfaction with system fit and comfort compared to PD patients.
- Older age correlated negatively with satisfaction concerning the battery recharging process.
Conclusions:
- Rechargeable DBS systems are suitable for dystonia patients due to their high energy needs and end-of-life issues with older devices.
- In Parkinson's disease, younger patients with good technical aptitude and no cognitive impairment are predicted to gain the most benefit.
- Patient satisfaction is a critical factor in the adoption and success of advanced neurostimulation technologies.
